NCT00620802View on ClinicalTrials.gov

Pharmacodynamics of CGT 2168 Compared With Plavix®

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Healthy
Interventions
DRUG

CGT-2168

(CGT-2168, one capsule each daily)

DRUG

Plavix

(clopidogrel, 75 mg)

Trial Locations (1)

66211

Quintiles Phase I Services, Overland Park

Sponsors
All Listed Sponsors
lead

Cogentus Pharmaceuticals

INDUSTRY

NCT00620802 - Pharmacodynamics of CGT 2168 Compared With Plavix® | Biotech Hunter | Biotech Hunter